Green Thumb Industries Inc. GTBIF
We take great care to ensure that the data presented and summarized in this overview for Green Thumb Industries Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GTBIF
View all-
Gofen & Glossberg LLC128KShares$715,1080.03% of portfolio
-
Westerly Capital Management, LLC San Francisco, CA100KShares$560,0000.49% of portfolio
-
Albert D Mason Inc93.9KShares$526,0360.44% of portfolio
-
Thompson Investment Management, Inc.76.6KShares$428,7360.07% of portfolio
-
Rothschild Investment Corp43.5KShares$243,5990.04% of portfolio
-
Vermillion & White Wealth Management Group, LLC Phoenixville, PA29.1KShares$163,0040.18% of portfolio
-
Hurley Capital, LLC New York, NY1.56KShares$8,7580.01% of portfolio
-
Org Partners LLC Roanoke, IN1.19KShares$6,6360.0% of portfolio
-
Horrell Capital Management, Inc.500Shares$2,8000.0% of portfolio
-
Game Plan Financial Advisors, LLC300Shares$1,6800.0% of portfolio
Latest Institutional Activity in GTBIF
Top Purchases
Top Sells
About GTBIF
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Insider Transactions at GTBIF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 01
2025
|
Anthony Georgiadis PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
9,979
-0.98%
|
$49,895
$5.81 P/Share
|
|
Apr 01
2025
|
Anthony Georgiadis PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
97,996
+8.76%
|
-
|
|
Apr 01
2025
|
Mathew Faulkner CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,405
-1.06%
|
$27,025
$5.81 P/Share
|
|
Apr 01
2025
|
Mathew Faulkner CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
84,930
+14.27%
|
-
|
|
Apr 01
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
4,300
-0.8%
|
$21,500
$5.81 P/Share
|
|
Apr 01
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
39,198
+6.81%
|
-
|
|
Apr 01
2025
|
Benjamin Kovler CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,613
-0.28%
|
$13,065
$5.81 P/Share
|
|
Apr 01
2025
|
Benjamin Kovler CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
52,264
+5.24%
|
-
|
|
Mar 05
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Open market or private sale
|
Direct |
160,000
-24.33%
|
$960,000
$6.49 P/Share
|
|
Mar 04
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Open market or private sale
|
Direct |
7,748
-1.16%
|
$46,488
$6.68 P/Share
|
|
Mar 01
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,169
-0.18%
|
$7,014
$6.95 P/Share
|
|
Mar 01
2025
|
Mathew Faulkner CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,040
-0.71%
|
$18,240
$6.95 P/Share
|
|
Mar 01
2025
|
Benjamin Kovler CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-0.14%
|
$7,482
$6.95 P/Share
|
|
Mar 01
2025
|
Dawn Wilson Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+12.82%
|
-
|
|
Mar 01
2025
|
Ethan Nadelmann |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+14.73%
|
-
|
|
Mar 01
2025
|
Hannah Scofield Buchan |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+13.62%
|
-
|
|
Mar 01
2025
|
Jeffrey H Goldman |
BUY
Grant, award, or other acquisition
|
Direct |
8,093
+0.58%
|
-
|
|
Mar 01
2025
|
Richard Reisin |
BUY
Grant, award, or other acquisition
|
Direct |
8,633
+19.61%
|
-
|
|
Jan 02
2025
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
2,898
-0.43%
|
$23,184
$8.39 P/Share
|
|
Jan 02
2025
|
Mathew Faulkner CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,220
-0.75%
|
$25,760
$8.39 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.49M shares |
|---|---|
| Exercise of conversion of derivative security | 400K shares |
| Exercise of in-the-money or at-the-money derivatives securities | 146 shares |
| Open market or private purchase | 632 shares |
| Payment of exercise price or tax liability | 364K shares |
|---|---|
| Open market or private sale | 249K shares |